27 results
8-K
PULM
Pulmatrix Inc
4 Mar 24
Regulation FD Disclosure
4:06pm
and/or distribute to the investment community and utilize at various industry and other conferences a slide presentation, which is attached hereto as Exhibit 99.1
8-K
PULM
Pulmatrix Inc
8 Jan 24
Entry into a Material Definitive Agreement
9:00am
FD Disclosure.
The Company also intends, from time to time, to present and/or distribute to the investment community and utilize at various industry
8-K
PULM
Pulmatrix Inc
11 Jul 23
Pulmatrix Announces Submission of IND Application to FDA to Initiate a Phase 2 Trial of Investigational Drug PUR3100 to Treat Acute Migraine
9:05am
, from time to time, to present and/or distribute to the investment community and utilize at various industry and other conferences a slide presentation
8-K
PULM
Pulmatrix Inc
14 Nov 22
Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update
6:17am
, from time to time, to present and/or distribute to the investment community and utilize at various industry and other conferences a slide
8-K
PULM
Pulmatrix Inc
12 Jul 22
Pulmatrix Announces First Subject Dosed in Phase 1 Study of PUR3100 for Acute Migraine
9:00am
to the Company. The Company may, from time to time, present and/or distribute to the investment community and utilize the slide presentation at various industry
8-K
b2b0k
12 May 22
Pulmatrix Announces First Quarter 2022 Financial Results and Provides Corporate Update
9:15am
8-K
b5cl7 4pf49bat
29 Mar 22
Pulmatrix Announces Year-End and Q4 Financial 2021 Results and Provides Corporate Update
9:15am
DEFA14A
u5v4q kjx2luz9w9
1 Feb 22
Additional proxy soliciting materials
9:10am
8-K
zrcuvc83gm
7 Dec 21
Regulation FD Disclosure
9:25am
8-K
1t896qt2 8hz7ees
13 May 21
Regulation FD Disclosure
10:26am
8-K
bri1p0e5wdf36qno8j
12 Apr 21
Termination of a Material Definitive Agreement
9:15am
8-K
b2qtmikid4us pt
2 Dec 20
Regulation FD Disclosure
11:32am
8-K
b4c xbkeqh5hls
22 Sep 20
Regulation FD Disclosure
9:10am
8-K
ths2jz8qwhiusc
17 Jun 20
Regulation FD Disclosure
8:30am
8-K
s1mmbfl8 1y
24 Apr 20
Regulation FD Disclosure
4:26pm
8-K
men1al6y
13 Jan 20
Regulation FD Disclosure
8:45am
8-K
8xhl2x9mta3junoj
22 Aug 19
Regulation FD Disclosure
9:00am
8-K
EX-99.1
vj6bf
15 Apr 19
Pulmatrix and Cipla Technologies LLC enter into Definitive Agreement for the Development and Commercialization of PulmazoleTM
5:00pm
8-K
EX-99.1
u3y1zd6 94cv3h
1 Apr 19
Entry into a Material Definitive Agreement
4:16pm
8-K
xpy8ycxtj74fro
1 Aug 18
Regulation FD Disclosure
3:31pm